New York State Psychiatric Institute
New York State Psychiatric Institute
New York, New York, United States22 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06793397 | |
| Pramipexole to Enhance Social Connections | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-09-23 | NCT06269146 | |
| DecNef for AVH in Schizophrenia | Hallucinations, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, nervous system disorder, perceptual disorders, psychiatric disorder, schizophrenia | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT07779226 | |
| Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder | Bipolar and Related Disorders, bipolar disorder, depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 4 | 2026-09-08 | NCT07806227 | |
| Olfactory Training in Mild Cognitive Impairment | Cognition Disorders, Cognitive Dysfunction, Memory Disorders, Mild Cognitive Impairment, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, anosmia, cognitive disorder, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-04 | NCT06825403 | |
| Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT05711940 | |
| Air Pollution and Development in the Boricua Youth Study | neurodevelopmental disorder, psychiatric disorder | Enrolling by invitation | Not applicable | 2026-08-06 | NCT05368493 | |
| Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 4 | 2026-08-03 | NCT07139106 | |
| An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-08-03 | NCT06518941 | |
| Sleep Interventions and Neurocognitive Outcomes | Alzheimer disease, Parasomnias, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, sleep disorder, sleep-wake disorder, tauopathy | Not yet recruiting | Not applicable | 2026-08-03 | NCT05987007 | |
| Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications | Negative Symptoms of Schizophrenia | Recruiting | Phase 3 | 2026-07-28 | NCT07565428 | |
| How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD | obsessive-compulsive personality disorder | Recruiting | Not applicable | 2026-07-22 | NCT05359562 | |
| Effects of rTMS on Food Choice in Anorexia Nervosa | Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorder | Recruiting | Not applicable | 2026-07-15 | NCT05918835 | |
| A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia | SCHIZOPHRENIA 1 (Disorder); Schizoaffecitve Disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-14 | NCT07423546 | |
| Exercise and Olanzapine-samidorphan | Bipolar and Related Disorders, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar disorder, mood disorder, psychiatric disorder, schizoaffective disorder | Recruiting | Phase 4 | 2026-07-13 | NCT06740890 | |
| Facilitating Opioid Care Connections | Medication to Treat Opioid Use Disorder; Opioid Court Model; Opioid Use | Active, not recruiting | Not applicable | 2026-06-30 | NCT04216719 | |
| Relapse Prevention and Changing Habits in Anorexia Nervosa | Feeding and Eating Disorders, anorexia nervosa, psychiatric disorder | Recruiting | Not applicable | 2026-06-01 | NCT04810624 | |
| Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizoaffective disorder, schizophrenia | Recruiting | Phase 4 | 2026-05-04 | NCT05208190 | |
| Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil) | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not applicable | 2026-04-23 | NCT05477901 | |
| Sublingual Dexmedetomidine for Treating Opioid Withdrawal | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-14 | NCT05712707 | |
| Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial | COVID-19, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, cognitive disorder, depressive disorder, long COVID-19, lung disorder, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2024-07-16 | NCT05690503 | |
| Facilitating Rapid Naltrexone Initiation | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 3 | 2024-02-02 | NCT03345173 |